6
Oct
2026

CuraTeQ Biologics Private Limited

Exhibitor at CPHI Milan 2026 stand 5F18, Integrated Pharma
About Us

CuraTeQ Biologics is an EU GMP certified biopharmaceutical company. We have a pipeline of 14 biosimilars:

  • Bevqolva (Bevacizumab) received MHRA approval
  • Zefylti (Filgrastim) & Dyrupeg (Pegfilgrastim) received EC & MHRA approvals
  • Dazublys (Trastuzumab) received EC, MHRA, & CDSCO approvals
Auro Peptides, our synthetic peptide API manufacturing arm, has filed 14 US DMFs contributing to 6 ANDA approvals. We also offer CMO services in biologics & peptides.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    India
  • On CPHI since:
    2024
  • Certificates:
    1
  • Employees:
    250 - 499
Company types
Biopharmaceutical company
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Biopharmaceutical
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Pharmaceutical Company (generic finished products)
View company profile
Contact info
  • 9618569568
  • Survey No. 77 & 78, Indrakaran Village,, Kandi Mandal, Sangareddy District, 502329, Hyderabad, Telangana, India
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 5F18, Integrated Pharma